Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
PremiumThe FlyCellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
22d ago
Cellectar Biosciences sees cash runway into 4Q25
Premium
The Fly
Cellectar Biosciences sees cash runway into 4Q25
22d ago
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Cellectar Biosciences Strategic Shift and Workforce Reduction
PremiumCompany AnnouncementsCellectar Biosciences Strategic Shift and Workforce Reduction
4M ago
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
4M ago
Cellectar Biosciences trading resumes
Premium
The Fly
Cellectar Biosciences trading resumes
4M ago
Cellectar Biosciences Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsCellectar Biosciences Reports Q3 2024 Financial Results
5M ago
Cellectar Biosciences reports Q3 EPS (40c), consensus (37c)
Premium
The Fly
Cellectar Biosciences reports Q3 EPS (40c), consensus (37c)
5M ago
Cellectar Biosciences sees cash runway into 2Q25
Premium
The Fly
Cellectar Biosciences sees cash runway into 2Q25
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100